Where can I buy shares of Tak?
Apr 14, 2022 · Takeda Pharmaceutical's stock was trading at $17.15 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TAK stock has decreased by 14.6% and is now trading at $14.64. View which stocks have been most impacted by COVID-19.
Who bought Tatak stock last quarter?
May 02, 2022 · A high-level overview of Takeda Pharmaceutical Company Limited (TAK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Where can I buy Takeda Pharmaceuticals stock?
5 rows · Real time Takeda Pharmaceutical Company (TAK) stock price quote, stock graph, news & ...
What does tak-721 stand for?
TAK: Get the latest Takeda Pharmaceutical stock price and detailed information including TAK news, historical charts and realtime prices.
See more
May 05, 2022 · View Takeda Pharmaceutical Co TAK investment & stock information. Get the latest Takeda Pharmaceutical Co TAK detailed stock quotes, stock data, Real …
Does Takeda pay a dividend?
Is tak a good buy?
Why did Takeda stock drop?
Is Tak an ADR?
Is tak a buy or a sell?
...
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.97% |
| 2 | Buy | 18.45% |
| 3 | Hold | 10.03% |
| 4 | Sell | 5.70% |
Is Takeda stock a buy?
The 14 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 16.16, with a high estimate of 21.00 and a low estimate of 14.36. The median estimate represents a +12.76% increase from the last price of 14.34.
Why is tak stock so low?
Is Takeda a good company?
How much debt does Takeda have?
| Takeda Pharmaceutical Debt/Equity Ratio Historical Data | ||
|---|---|---|
| Date | Long Term Debt | Shareholder's Equity |
| 2020-03-31 | $74.46B | $43.49B |
| 2019-12-31 | $75.03B | $44.86B |
| 2019-09-30 | $74.50B | $45.29B |
Is Takeda Pharmaceutical a buy right now?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Takeda Pharmaceutical in the last twelve months. There a...
How has Takeda Pharmaceutical's stock been impacted by COVID-19 (Coronavirus)?
Takeda Pharmaceutical's stock was trading at $17.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World...
When is Takeda Pharmaceutical's next earnings date?
Takeda Pharmaceutical is scheduled to release its next quarterly earnings announcement on Tuesday, May 10th 2022. View our earnings forecast for T...
How were Takeda Pharmaceutical's earnings last quarter?
Takeda Pharmaceutical Company Limited (NYSE:TAK) issued its earnings results on Thursday, February, 3rd. The company reported $0.54 EPS for the qua...
Is Takeda Pharmaceutical a good dividend stock?
Takeda Pharmaceutical pays an annual dividend of $0.66 per share and currently has a dividend yield of 4.42%. TAK has a dividend yield higher than...
What guidance has Takeda Pharmaceutical issued on next quarter's earnings?
Takeda Pharmaceutical updated its FY 2021 earnings guidance on Monday, February, 21st. The company provided earnings per share guidance of $3.610-$...
Who are Takeda Pharmaceutical's key executives?
Takeda Pharmaceutical's management team includes the following people: Christophe Weber , President, CEO & Representative Director Constantine Sa...
Who are some of Takeda Pharmaceutical's key competitors?
Some companies that are related to Takeda Pharmaceutical include Bristol-Myers Squibb (BMY) , Sanofi (SNY) , GlaxoSmithKline (GSK) , CSL (CSLLY...
What other stocks do shareholders of Takeda Pharmaceutical own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Takeda Pharmaceutical investors own include Cisco Systems...
Is Takeda Pharmaceutical a buy right now?
What stocks does MarketBeat like better than Takeda Pharmaceutical?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Takeda Pharmaceutical in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Takeda Pharmaceutical stock.
When is Takeda Pharmaceutical's next earnings date?
Wall Street analysts have given Takeda Pharmaceutical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Takeda Pharmaceutical wasn't one of them.
How were Takeda Pharmaceutical's earnings last quarter?
Takeda Pharmaceutical is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.#N#View our earnings forecast for Takeda Pharmaceutical.
How has Takeda Pharmaceutical's stock been impacted by COVID-19?
Takeda Pharmaceutical Company Limited (NYSE:TAK) posted its earnings results on Friday, July, 30th. The company reported $0.51 earnings per share for the quarter. The firm had revenue of $8.68 billion for the quarter.
Is Takeda Pharmaceutical a good dividend stock?
Takeda Pharmaceutical's stock was trading at $17.15 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TAK stock has decreased by 1.0% and is now trading at $16.98.#N#View which stocks have been most impacted by COVID-19.
What guidance has Takeda Pharmaceutical issued on next quarter's earnings?
Takeda Pharmaceutical pays an annual dividend of $0.68 per share and currently has a dividend yield of 3.97%. TAK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Takeda Pharmaceutical is 34.34%. This payout ratio is at a healthy, sustainable level, below 75%.
